Procter & Gamble Co
NYSE : PG$159.35+0.20%Oct 16 close
Financials
Consolidated Statements of Earnings
USD · reported units. Click a value to inspect its source.
| Reported line item | Jul 1, 2025 to Jun 30, 2026 (current) | Jul 1, 2024 to Jun 30, 2025 | Jul 1, 2023 to Jun 30, 2024 |
|---|---|---|---|
| Income Statement [Abstract] | |||
| NET SALES | |||
| Cost of products sold | |||
| Selling, general and administrative expense | |||
| Indefinite-lived intangible asset impairment charge | |||
| OPERATING INCOME | |||
| Interest expense | |||
| Interest income | |||
| Other non-operating income/(expense), net | |||
| EARNINGS BEFORE INCOME TAXES | |||
| Income taxes | |||
| NET EARNINGS | |||
| Less: Net earnings attributable to noncontrolling interests | |||
| NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | |||
| NET EARNINGS PER COMMON SHARE | |||
| Basic (in dollars per share)USD / share | |||
| Diluted (in dollars per share)USD / share |
15 line items · 3 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.